Takeda Highlights Pioglitazone Fracture Risk In “Dear Healthcare Provider” Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA issues MedWatch alert March 9, the second time the agency has warned of fracture risk in women taking thiazolidinediones in recent weeks.